Body fat percentage is more strongly associated with biomarkers of low-grade inflammation than traditional cardiometabolic risk factors in healthy young adults – the Lifestyle, Biomarkers, and Atherosclerosis study

References

• Viola J, Soehnlein O. Atherosclerosis – a matter of unresolved inflammation. Semin Immunol. 2015;27:184–193.
   PubMed Web of Science ®Google Scholar
• Breimer LH, Sourander P. Fåhraeus and erythrocyte sedimentation. Lancet. 1987;1:1091.
   PubMed Web of Science ®Google Scholar
• Yayan J. Erythrocyte sedimentation rate as a marker for coronary heart disease. Vasc Health Risk Manag. 2012;8:219–223.
   PubMedGoogle Scholar
• Koenig W. High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy. Int J Cardiol. 2013;168:5126–5134.
   PubMed Web of Science ®Google Scholar
• Jialal I, Devaraj S, Venugopal SK. C-reactive protein: risk marker or mediator in atherothrombosis? Hypertension. 2004;44:6–11.
   PubMed Web of Science ®Google Scholar
• Ouchi N, Parker JL, Lugus JJ, et al. Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2011;11:85–97.
   PubMed Web of Science ®Google Scholar
• Knight JA. Diseases and disorders associated with excess body weight. Ann Clin Lab Sci. 2011;41:107–121.
   PubMed Web of Science ®Google Scholar
• Kloting N, Bluher M. Adipocyte dysfunction, inflammation and metabolic syndrome. Rev Endocr Metab Disord. 2014;15:277–287.
   PubMed Web of Science ®Google Scholar
• Després J-P, Lemieux I, Bergeron J, et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. ATVB. 2008;28:1039–1049.
   Web of Science ®Google Scholar
• Kindmark CO, Laurell CB, Iwarson S, et al. Sequential changes of the plasma-protein pattern in cases of hepatitis A. Ups J Med Sci. 1988;93:233–244.
   PubMed Web of Science ®Google Scholar
• Alfadda AA, Fatma S, Chishti MA, et al. Orosomucoid serum concentrations and fat depot-specific mRNA and protein expression in humans. Mol Cells. 2012;33:35–41.
   PubMed Web of Science ®Google Scholar
• Engström G, Lind P, Hedblad B, et al. Effects of cholesterol and inflammation-sensitive plasma proteins on incidence of myocardial infarction and stroke in men. Circulation. 2002;105:2632–2637.
   PubMed Web of Science ®Google Scholar
• Kayser BD, Lhomme M, Dao MC, et al. Serum lipidomics reveals early differential effects of gastric bypass compared with banding on phospholipids and sphingolipids independent of differences in weight loss. Int J Obes Relat Metab Disord. 2017;41:917–925.
   Web of Science ®Google Scholar
• Ference BA, Mahajan N. The role of early LDL lowering to prevent the onset of atherosclerotic disease. Curr Atheroscler Rep. 2013;15:312.
   PubMed Web of Science ®Google Scholar
• Laurell CB, Kullander S, Thorell J. Effect of administration of a combined estrogen-progestin contraceptive on the level of individual plasma proteins. Scand J Clin Lab Invest. 1968;21:337–343.
   PubMed Web of Science ®Google Scholar
• Laurell CB, Rannevik G. A comparison of plasma protein changes induced by danazol, pregnancy, and estrogens. J Clin Endocrinol Metab. 1979;49:719–725.
   PubMed Web of Science ®Google Scholar
• van Rooijen M, Hansson LO, Frostegård J, et al. Treatment with combined oral contraceptives induces a rise in serum C-reactive protein in the absence of a general inflammatory response. J Thromb Haemost. 2006;4:77–82.
   PubMed Web of Science ®Google Scholar
• Fernström M, Fernberg U, Eliason G, et al. Aerobic fitness is associated with low cardiovascular disease risk: the impact of lifestyle on early risk factors for atherosclerosis in young healthy Swedish individuals – the Lifestyle, Biomarker, and Atherosclerosis study. VHRM. 2017;13:91–99.
   Google Scholar
• Roubenoff R, Dallal GE, Wilson PW. Predicting body fatness: the body mass index vs estimation by bioelectrical impedance. Am J Public Health. 1995;85:726–728.
   PubMed Web of Science ®Google Scholar
• Jaffrin MY. Body composition determination by bioimpedance: an update. Curr Opin Clin Nutr Metab Care. 2009;12:482–486.
   PubMed Web of Science ®Google Scholar
• Ference BA, Ginsberg HN, Graham I, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2017;38:2459–2472.
   PubMed Web of Science ®Google Scholar
• Chung ST, Onuzuruike AU, Magge SN. Cardiometabolic risk in obese children. Ann N Y Acad Sci. 2018;1411:166–183.
   PubMed Web of Science ®Google Scholar
• Shimobayashi M, Albert V, Woelnerhanssen B, et al. Insulin resistance causes inflammation in adipose tissue. J Clin Invest. 2018;128:1538–1550.
   PubMed Web of Science ®Google Scholar
• Buchbinder S, Kratzsch J, Fiedler GM, et al. Body weight and oral contraceptives are the most important modulators of serum CRP levels. Scand J Clin Lab Invest. 2008;68:140–144.
   PubMed Web of Science ®Google Scholar
• Fournier T, Medjoubi NN, Porquet D. Alpha-1-acid glycoprotein. Biochim Biophys Acta. 2000;1482:157–171.
   PubMed Web of Science ®Google Scholar
• Berntsson J, Östling G, Persson M, et al. Orosomucoid, carotid plaque, and incidence of stroke. Stroke. 2016;47:1858–1863.
   PubMed Web of Science ®Google Scholar
• Emerging Risk Factors Collaboration, Sarwar N, Gao P, Seshasai SR, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet (London, England). 2010;375:2215–2222.
   PubMed Web of Science ®Google Scholar
• Rocha VZ, Libby P. Obesity, inflammation, and atherosclerosis. Nat Rev Cardiol. 2009;6:399–409.
   PubMed Web of Science ®Google Scholar
• Keustermans GC, Kofink D, Eikendal A, et al. Monocyte gene expression in childhood obesity is associated with obesity and complexity of atherosclerosis in adults. Sci Rep. 2017;7:16826.
   PubMed Web of Science ®Google Scholar
• Eikendal AL, Evelein AM, Uiterwaal CS, et al. Relation between circulating inflammatory chemokines and vascular characteristics in healthy, young children. J Am Heart Assoc. 2015;4:e002346.
   PubMed Web of Science ®Google Scholar
• Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature. 2006;444:875–880.
   PubMed Web of Science ®Google Scholar
• Fülöp P, Harangi M, Seres I, et al. Paraoxonase-1 and adipokines: potential links between obesity and atherosclerosis. Chem Biol Interact. 2016;259:388–393.
   PubMed Web of Science ®Google Scholar